Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/76358
Title: Targeted next generation sequencing identified novel mutations in RPGRIP1 associated with both retinitis pigmentosa and Leber's congenital amaurosis in unrelated Chinese patients
Authors: Huang, H
Wang, Y
Chen, HS
Chen, YH
Wu, J
Chiang, PW
Fan, N
Su, Y
Deng, JL
Chen, DN
Li, Y
Zhang, XX
Zhang, MX 
Liang, SR
Banerjee, S
Qi, M
Liu, XY
Keywords: Targeted next generation sequencing
Gene panel
Novel mutation
Retinitis pigmentosa
Leber's congenital amaurosis
Issue Date: 2017
Publisher: Impact Journals LLC
Source: Oncotarget, 2017, v. 8, no. 21, p. 35176-35183 How to cite?
Journal: Oncotarget 
Abstract: As the most common inherited retinal degenerations, retinitis pigmentosa (RP) is clinically and genetically heterogeneous. Some of the RP genes are also associated with other retinal diseases, such as LCA (Leber's congenital amaurosis) and CORD (cone-rod dystrophy). Here, in our molecular diagnosis of 99 Chinese RP patients using targeted gene capture sequencing, three probands were found to carry mutations of RPGRIP1, which was known to be associated with pathogenesis of LCA and CORD. By further clinical analysis, two probands were confirmed to be RP patients and one was confirmed to be LCA patient. These novel mutations were co-segregated with the disease phenotype in their families. Our result not only expands the mutational spectrum of the RPGRIP1 gene but also gives supports to clinical diagnosis and molecular treatment of RP patients.
URI: http://hdl.handle.net/10397/76358
ISSN: 1949-2553
DOI: 10.18632/oncotarget.17052
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

SCOPUSTM   
Citations

4
Citations as of Dec 5, 2018

WEB OF SCIENCETM
Citations

4
Last Week
0
Last month
Citations as of Dec 13, 2018

Page view(s)

27
Last Week
0
Last month
Citations as of Dec 9, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.